SCHEMBL9435019

SCHEMBL9435019

CCOC(=O)C1=Nc2cc3c(c(C)c2=C1C)N=c1c(OC)c(OC(C)=O)ccc1=3

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
MAPT P10636 4/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP2C19 P33261 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
GAA P10253 1/20 0.31
HTT P42858 2/20 0.31
LMNA P02545 1/20 0.31
HSP90AA1 P07900 1/20 0.31
HIF1A Q16665 1/20 0.31
SLC5A1 P13866 1/20 0.30
SLC5A2 P31639 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9434368 0.71 SMN1; SMN2 (0.36) ALDH1A1MAPTCYP1A2NPSR1NPC1
SCHEMBL9434365 0.71 FGB (0.42) ALDH1A1MAPTCYP1A2NPC1RAB9A
SCHEMBL8911552 0.69 SMN1; SMN2 (0.36) ALDH1A1MAPTCYP1A2CYP3A4NPSR1
SCHEMBL8910142 0.66 GAA (0.33) ALDH1A1MAPTCYP1A2CYP3A4NPSR1
SCHEMBL7965432 0.65 MAPT (0.34) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL9435000 0.64 MAPT (0.32) MAPTMEN1KMT2AKDM4E
SCHEMBL8155848 0.61 PDE1C (0.36) MAPTMEN1KMT2ASMN1; SMN2GAA
SCHEMBL7966334 0.61 KDM4E (0.36) ALDH1A1MAPTNPSR1RAB9AMEN1
SCHEMBL7963227 0.61 LMNA (0.36) ALDH1A1MAPTCYP1A2NPSR1KDM4E
SCHEMBL8536893 0.61 MAPT (0.52) ALDH1A1MAPTCYP1A2CYP3A4NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed